Active, not recruitingPhase 1NCT05245968
A Study of Pimitespib in Combination With Imatinib in Patients With GIST (CHAPTER-GIST-101)
Studying Gastrointestinal stromal tumor
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Taiho Pharmaceutical Co., Ltd.
- Principal Investigator
- Taiho Pharmaceutical Co., Ltd.Taiho Pharmaceutical Co., Ltd.
- Intervention
- Pimitespib(drug)
- Enrollment
- 78 target
- Eligibility
- 18 years · All sexes
- Timeline
- 2021 – 2026
Study locations (14)
- Flinders Medical Center, Adelaide, Australia
- Alfred Health, Melbourne, Australia
- Beijing Cancer Hospital, Beijing, China
- Fudan University, Shanghai Cancer Center, Shanghai, China
- National Cancer Center Hospital East, Chiba, Japan
- Hokkaido University Hospital, Hokkaido, Japan
- Kumamoto University Hospital, Kumamoto, Japan
- Osaka University Hospital, Osaka, Japan
- National Cancer Center Hospital, Tokyo, Japan
- The Cancer Institute Hospital of JFCR, Tokyo, Japan
- National University Cancer Institute, Singapore, Singapore
- Kaohsiung Medical University Hospital, Kaohsiung City, Taiwan
- Linkou Chang Gung Memorial Hospital, Linkou District, Taiwan
- Taipei Veterans General Hospital, Taipei, Taiwan
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05245968 on ClinicalTrials.govOther trials for Gastrointestinal stromal tumor
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE1NCT07171203Neoadjuvant Imatinib and Fampridine in KIT Mutant Gastrointestinal Stromal TumorUniversity of California, San Diego
- RECRUITINGNANCT07405125Safety of Robotic Surgery for GISTs at Special Anatomic SitesThe First Affiliated Hospital with Nanjing Medical University
- RECRUITINGPHASE3NCT07218926A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib TherapyGlaxoSmithKline
- RECRUITINGPHASE1NCT06655246A Study of Ziftomenib in Combination With Imatinib in Patients With Advanced Gastrointestinal Stromal Tumors (GIST)Kura Oncology, Inc.
- RECRUITINGNANCT06926374Prospective Evaluation of Cornerstone Robotics Sentire Surgical System in Major Gastrointestinal and Urologic SurgeryChinese University of Hong Kong
- RECRUITINGNANCT07411118RCT of EFTR Versus STER for GIST TreatmentChinese University of Hong Kong
- RECRUITINGPHASE1, PHASE2NCT06630234A Master Protocol to Evaluate DCC-3009 in Gastrointestinal Stromal Tumor (GIST)Deciphera Pharmaceuticals, LLC
- RECRUITINGPHASE3NCT06640361A Study of Olverembatinib in SDH-deficient GIST.Ascentage Pharma Group Inc.